nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—BCHE—Triamcinolone—psoriasis	0.117	0.14	CbGbCtD
Clevidipine—CYP1A2—Clobetasol propionate—psoriasis	0.112	0.134	CbGbCtD
Clevidipine—CYP1A2—Methoxsalen—psoriasis	0.059	0.0705	CbGbCtD
Clevidipine—CYP2D6—Hydroxyurea—psoriasis	0.0532	0.0635	CbGbCtD
Clevidipine—CYP2C19—Cholecalciferol—psoriasis	0.0424	0.0506	CbGbCtD
Clevidipine—CYP3A4—Calcitriol—psoriasis	0.0397	0.0475	CbGbCtD
Clevidipine—CACNA1S—pes—psoriasis	0.039	0.893	CbGeAlD
Clevidipine—CYP2C9—Cholecalciferol—psoriasis	0.0352	0.0421	CbGbCtD
Clevidipine—CYP2D6—Cholecalciferol—psoriasis	0.0322	0.0385	CbGbCtD
Clevidipine—CYP3A4—Methoxsalen—psoriasis	0.0309	0.0369	CbGbCtD
Clevidipine—CYP2C19—Prednisone—psoriasis	0.0294	0.0351	CbGbCtD
Clevidipine—CYP2E1—Dexamethasone—psoriasis	0.0292	0.0349	CbGbCtD
Clevidipine—CYP2C19—Cyclosporine—psoriasis	0.0278	0.0333	CbGbCtD
Clevidipine—CYP2C9—Cyclosporine—psoriasis	0.0231	0.0277	CbGbCtD
Clevidipine—CYP2D6—Cyclosporine—psoriasis	0.0212	0.0253	CbGbCtD
Clevidipine—CYP3A4—Cholecalciferol—psoriasis	0.0205	0.0245	CbGbCtD
Clevidipine—CYP2C19—Dexamethasone—psoriasis	0.0183	0.0219	CbGbCtD
Clevidipine—CYP3A4—Triamcinolone—psoriasis	0.0178	0.0212	CbGbCtD
Clevidipine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0178	0.0212	CbGbCtD
Clevidipine—CYP2C9—Dexamethasone—psoriasis	0.0152	0.0182	CbGbCtD
Clevidipine—CYP3A4—Betamethasone—psoriasis	0.0152	0.0182	CbGbCtD
Clevidipine—CYP3A4—Prednisolone—psoriasis	0.015	0.018	CbGbCtD
Clevidipine—CYP3A4—Hydrocortisone—psoriasis	0.0142	0.017	CbGbCtD
Clevidipine—CYP3A4—Prednisone—psoriasis	0.0142	0.017	CbGbCtD
Clevidipine—CYP2D6—Dexamethasone—psoriasis	0.0139	0.0167	CbGbCtD
Clevidipine—CYP3A4—Cyclosporine—psoriasis	0.0135	0.0161	CbGbCtD
Clevidipine—CYP3A4—Dexamethasone—psoriasis	0.00886	0.0106	CbGbCtD
Clevidipine—Blood triglycerides increased—Tazarotene—psoriasis	0.00842	0.109	CcSEcCtD
Clevidipine—Blood triglycerides increased—Acitretin—psoriasis	0.00403	0.052	CcSEcCtD
Clevidipine—CACNA1S—tendon—psoriasis	0.00299	0.0684	CbGeAlD
Clevidipine—Ileus—Mycophenolic acid—psoriasis	0.00245	0.0317	CcSEcCtD
Clevidipine—CYP2E1—CYP2E1 reactions—CYP2S1—psoriasis	0.00244	0.0582	CbGpPWpGaD
Clevidipine—Blood triglycerides increased—Cyclosporine—psoriasis	0.00214	0.0277	CcSEcCtD
Clevidipine—Hypersensitivity—Calcipotriol—psoriasis	0.00197	0.0254	CcSEcCtD
Clevidipine—Ileus—Mycophenolate mofetil—psoriasis	0.00194	0.025	CcSEcCtD
Clevidipine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00188	0.0449	CbGpPWpGaD
Clevidipine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00173	0.0413	CbGpPWpGaD
Clevidipine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00171	0.041	CbGpPWpGaD
Clevidipine—Renal failure acute—Hydroxyurea—psoriasis	0.00163	0.021	CcSEcCtD
Clevidipine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00161	0.0385	CbGpPWpGaD
Clevidipine—CYP2E1—Xenobiotics—CYP2S1—psoriasis	0.00151	0.0361	CbGpPWpGaD
Clevidipine—Blood triglycerides increased—Prednisone—psoriasis	0.00142	0.0183	CcSEcCtD
Clevidipine—Renal failure acute—Mycophenolic acid—psoriasis	0.00137	0.0176	CcSEcCtD
Clevidipine—Atrial fibrillation—Mycophenolic acid—psoriasis	0.00133	0.0172	CcSEcCtD
Clevidipine—Hypersensitivity—Clobetasol propionate—psoriasis	0.00123	0.0159	CcSEcCtD
Clevidipine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.00117	0.0278	CbGpPWpGaD
Clevidipine—Hypotension—Methoxsalen—psoriasis	0.00111	0.0143	CcSEcCtD
Clevidipine—Hypersensitivity—Fluocinonide—psoriasis	0.00111	0.0143	CcSEcCtD
Clevidipine—Renal failure acute—Mycophenolate mofetil—psoriasis	0.00108	0.0139	CcSEcCtD
Clevidipine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.00107	0.0256	CbGpPWpGaD
Clevidipine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.00106	0.0254	CbGpPWpGaD
Clevidipine—Atrial fibrillation—Mycophenolate mofetil—psoriasis	0.00105	0.0135	CcSEcCtD
Clevidipine—Headache—Clobetasol propionate—psoriasis	0.00105	0.0135	CcSEcCtD
Clevidipine—BCHE—skin of body—psoriasis	0.00104	0.0239	CbGeAlD
Clevidipine—Headache—Beclomethasone—psoriasis	0.000952	0.0123	CcSEcCtD
Clevidipine—Headache—Fluocinonide—psoriasis	0.000943	0.0122	CcSEcCtD
Clevidipine—CACNA1F—Alzheimers Disease—APOE—psoriasis	0.000925	0.0221	CbGpPWpGaD
Clevidipine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000908	0.0217	CbGpPWpGaD
Clevidipine—Nausea—Beclomethasone—psoriasis	0.000903	0.0116	CcSEcCtD
Clevidipine—Hypersensitivity—Methoxsalen—psoriasis	0.000876	0.0113	CcSEcCtD
Clevidipine—CACNA1S—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000803	0.0192	CbGpPWpGaD
Clevidipine—Hypersensitivity—Calcitriol—psoriasis	0.00078	0.0101	CcSEcCtD
Clevidipine—Acute coronary syndrome—Cyclosporine—psoriasis	0.000775	0.00999	CcSEcCtD
Clevidipine—Myocardial infarction—Cyclosporine—psoriasis	0.00077	0.00994	CcSEcCtD
Clevidipine—Acute coronary syndrome—Mycophenolate mofetil—psoriasis	0.000756	0.00975	CcSEcCtD
Clevidipine—Myocardial infarction—Mycophenolate mofetil—psoriasis	0.000752	0.00969	CcSEcCtD
Clevidipine—Headache—Methoxsalen—psoriasis	0.000744	0.0096	CcSEcCtD
Clevidipine—Nausea—Methoxsalen—psoriasis	0.000706	0.00911	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisolone—psoriasis	0.000705	0.00909	CcSEcCtD
Clevidipine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000701	0.0167	CbGpPWpGaD
Clevidipine—Myocardial infarction—Prednisolone—psoriasis	0.000701	0.00904	CcSEcCtD
Clevidipine—Hypersensitivity—Acitretin—psoriasis	0.000694	0.00896	CcSEcCtD
Clevidipine—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000692	0.00893	CcSEcCtD
Clevidipine—Acute coronary syndrome—Hydrocortisone—psoriasis	0.000689	0.00888	CcSEcCtD
Clevidipine—Myocardial infarction—Hydrocortisone—psoriasis	0.000685	0.00883	CcSEcCtD
Clevidipine—Vomiting—Calcitriol—psoriasis	0.000673	0.00869	CcSEcCtD
Clevidipine—CYP2E1—tendon—psoriasis	0.000666	0.0152	CbGeAlD
Clevidipine—Headache—Calcitriol—psoriasis	0.000664	0.00856	CcSEcCtD
Clevidipine—Dyspnoea—Hydroxyurea—psoriasis	0.00066	0.00851	CcSEcCtD
Clevidipine—CACNA1D—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000652	0.0156	CbGpPWpGaD
Clevidipine—Acute coronary syndrome—Triamcinolone—psoriasis	0.000648	0.00836	CcSEcCtD
Clevidipine—Myocardial infarction—Triamcinolone—psoriasis	0.000645	0.00832	CcSEcCtD
Clevidipine—Nausea—Calcitriol—psoriasis	0.000629	0.00812	CcSEcCtD
Clevidipine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000627	0.015	CbGpPWpGaD
Clevidipine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—psoriasis	0.00062	0.0148	CbGpPWpGaD
Clevidipine—CYP2E1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000619	0.0148	CbGpPWpGaD
Clevidipine—Renal failure acute—Methotrexate—psoriasis	0.00061	0.00788	CcSEcCtD
Clevidipine—Tachycardia—Mycophenolic acid—psoriasis	0.000605	0.0078	CcSEcCtD
Clevidipine—Vomiting—Acitretin—psoriasis	0.000599	0.00773	CcSEcCtD
Clevidipine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000597	0.00771	CcSEcCtD
Clevidipine—Headache—Acitretin—psoriasis	0.00059	0.00762	CcSEcCtD
Clevidipine—Headache—Fluocinolone Acetonide—psoriasis	0.000589	0.00759	CcSEcCtD
Clevidipine—Acute coronary syndrome—Dexamethasone—psoriasis	0.000588	0.00759	CcSEcCtD
Clevidipine—Acute coronary syndrome—Betamethasone—psoriasis	0.000588	0.00759	CcSEcCtD
Clevidipine—Myocardial infarction—Dexamethasone—psoriasis	0.000585	0.00755	CcSEcCtD
Clevidipine—Myocardial infarction—Betamethasone—psoriasis	0.000585	0.00755	CcSEcCtD
Clevidipine—Hypotension—Mycophenolic acid—psoriasis	0.000579	0.00747	CcSEcCtD
Clevidipine—CACNA1C—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	0.000573	0.0137	CbGpPWpGaD
Clevidipine—Nausea—Acitretin—psoriasis	0.00056	0.00722	CcSEcCtD
Clevidipine—Nausea—Fluocinolone Acetonide—psoriasis	0.000558	0.0072	CcSEcCtD
Clevidipine—Dyspnoea—Mycophenolic acid—psoriasis	0.000552	0.00713	CcSEcCtD
Clevidipine—Hypersensitivity—Hydroxyurea—psoriasis	0.000545	0.00703	CcSEcCtD
Clevidipine—Acute coronary syndrome—Prednisone—psoriasis	0.000512	0.00661	CcSEcCtD
Clevidipine—Myocardial infarction—Prednisone—psoriasis	0.000509	0.00657	CcSEcCtD
Clevidipine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000509	0.0121	CbGpPWpGaD
Clevidipine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000484	0.0116	CbGpPWpGaD
Clevidipine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000478	0.0114	CbGpPWpGaD
Clevidipine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000477	0.00616	CcSEcCtD
Clevidipine—Vomiting—Hydroxyurea—psoriasis	0.00047	0.00607	CcSEcCtD
Clevidipine—Headache—Hydroxyurea—psoriasis	0.000463	0.00598	CcSEcCtD
Clevidipine—Hypotension—Mycophenolate mofetil—psoriasis	0.000457	0.00589	CcSEcCtD
Clevidipine—Dyspnoea—Cyclosporine—psoriasis	0.000447	0.00577	CcSEcCtD
Clevidipine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000445	0.0106	CbGpPWpGaD
Clevidipine—Tachycardia—Prednisolone—psoriasis	0.000445	0.00574	CcSEcCtD
Clevidipine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000441	0.0105	CbGpPWpGaD
Clevidipine—BCHE—Peptide hormone metabolism—REN—psoriasis	0.000441	0.0105	CbGpPWpGaD
Clevidipine—Nausea—Hydroxyurea—psoriasis	0.000439	0.00567	CcSEcCtD
Clevidipine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000439	0.0105	CbGpPWpGaD
Clevidipine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000436	0.00562	CcSEcCtD
Clevidipine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000436	0.0104	CbGpPWpGaD
Clevidipine—Tachycardia—Hydrocortisone—psoriasis	0.000435	0.00561	CcSEcCtD
Clevidipine—CACNA1F—Alzheimers Disease—TNF—psoriasis	0.000428	0.0102	CbGpPWpGaD
Clevidipine—Hypotension—Hydrocortisone—psoriasis	0.000416	0.00537	CcSEcCtD
Clevidipine—Tachycardia—Triamcinolone—psoriasis	0.000409	0.00528	CcSEcCtD
Clevidipine—Vomiting—Mycophenolic acid—psoriasis	0.000394	0.00508	CcSEcCtD
Clevidipine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000392	0.00937	CbGpPWpGaD
Clevidipine—Headache—Mycophenolic acid—psoriasis	0.000388	0.00501	CcSEcCtD
Clevidipine—CACNA1F—Alzheimers Disease—TP53—psoriasis	0.000377	0.00901	CbGpPWpGaD
Clevidipine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000377	0.00901	CbGpPWpGaD
Clevidipine—Dyspnoea—Triamcinolone—psoriasis	0.000374	0.00482	CcSEcCtD
Clevidipine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000372	0.00889	CbGpPWpGaD
Clevidipine—Tachycardia—Dexamethasone—psoriasis	0.000371	0.00479	CcSEcCtD
Clevidipine—Tachycardia—Betamethasone—psoriasis	0.000371	0.00479	CcSEcCtD
Clevidipine—CACNA1S—Alzheimers Disease—APOE—psoriasis	0.000371	0.00887	CbGpPWpGaD
Clevidipine—Hypersensitivity—Cyclosporine—psoriasis	0.000369	0.00476	CcSEcCtD
Clevidipine—Nausea—Mycophenolic acid—psoriasis	0.000368	0.00475	CcSEcCtD
Clevidipine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000361	0.00862	CbGpPWpGaD
Clevidipine—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00036	0.00465	CcSEcCtD
Clevidipine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000358	0.00855	CbGpPWpGaD
Clevidipine—Hypotension—Dexamethasone—psoriasis	0.000356	0.00459	CcSEcCtD
Clevidipine—Hypotension—Betamethasone—psoriasis	0.000356	0.00459	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisolone—psoriasis	0.000336	0.00434	CcSEcCtD
Clevidipine—Hypersensitivity—Hydrocortisone—psoriasis	0.000328	0.00423	CcSEcCtD
Clevidipine—Tachycardia—Prednisone—psoriasis	0.000323	0.00417	CcSEcCtD
Clevidipine—CACNA1S—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.00032	0.00763	CbGpPWpGaD
Clevidipine—Vomiting—Cyclosporine—psoriasis	0.000319	0.00411	CcSEcCtD
Clevidipine—Headache—Cyclosporine—psoriasis	0.000314	0.00405	CcSEcCtD
Clevidipine—Vomiting—Mycophenolate mofetil—psoriasis	0.000311	0.00401	CcSEcCtD
Clevidipine—Hypersensitivity—Triamcinolone—psoriasis	0.000309	0.00399	CcSEcCtD
Clevidipine—Headache—Mycophenolate mofetil—psoriasis	0.000306	0.00395	CcSEcCtD
Clevidipine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000306	0.0073	CbGpPWpGaD
Clevidipine—CACNA1D—Alzheimers Disease—APOE—psoriasis	0.000302	0.0072	CbGpPWpGaD
Clevidipine—Nausea—Cyclosporine—psoriasis	0.000298	0.00384	CcSEcCtD
Clevidipine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000291	0.00695	CbGpPWpGaD
Clevidipine—Nausea—Mycophenolate mofetil—psoriasis	0.00029	0.00375	CcSEcCtD
Clevidipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000288	0.00688	CbGpPWpGaD
Clevidipine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000287	0.00686	CbGpPWpGaD
Clevidipine—Headache—Prednisolone—psoriasis	0.000286	0.00369	CcSEcCtD
Clevidipine—Vomiting—Hydrocortisone—psoriasis	0.000283	0.00365	CcSEcCtD
Clevidipine—Headache—Hydrocortisone—psoriasis	0.000279	0.0036	CcSEcCtD
Clevidipine—BCHE—Peptide hormone metabolism—ACE—psoriasis	0.000275	0.00658	CbGpPWpGaD
Clevidipine—Nausea—Prednisolone—psoriasis	0.000271	0.0035	CcSEcCtD
Clevidipine—CYP2E1—Biological oxidations—CYP2S1—psoriasis	0.00027	0.00645	CbGpPWpGaD
Clevidipine—Vomiting—Triamcinolone—psoriasis	0.000267	0.00344	CcSEcCtD
Clevidipine—CYP2E1—Metapathway biotransformation—CYP2S1—psoriasis	0.000266	0.00636	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—APOE—psoriasis	0.000265	0.00633	CbGpPWpGaD
Clevidipine—Nausea—Hydrocortisone—psoriasis	0.000265	0.00341	CcSEcCtD
Clevidipine—Headache—Triamcinolone—psoriasis	0.000263	0.00339	CcSEcCtD
Clevidipine—CACNA1D—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000259	0.0062	CbGpPWpGaD
Clevidipine—Hypotension—Methotrexate—psoriasis	0.000259	0.00334	CcSEcCtD
Clevidipine—Nausea—Triamcinolone—psoriasis	0.000249	0.00321	CcSEcCtD
Clevidipine—Dyspnoea—Methotrexate—psoriasis	0.000247	0.00319	CcSEcCtD
Clevidipine—Hypersensitivity—Prednisone—psoriasis	0.000244	0.00315	CcSEcCtD
Clevidipine—Vomiting—Betamethasone—psoriasis	0.000242	0.00312	CcSEcCtD
Clevidipine—Vomiting—Dexamethasone—psoriasis	0.000242	0.00312	CcSEcCtD
Clevidipine—Headache—Betamethasone—psoriasis	0.000238	0.00308	CcSEcCtD
Clevidipine—Headache—Dexamethasone—psoriasis	0.000238	0.00308	CcSEcCtD
Clevidipine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000236	0.00564	CbGpPWpGaD
Clevidipine—CYP2E1—Tryptophan metabolism—CAT—psoriasis	0.000233	0.00557	CbGpPWpGaD
Clevidipine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000233	0.00556	CbGpPWpGaD
Clevidipine—CACNA1C—NCAM signaling for neurite out-growth—TYK2—psoriasis	0.000228	0.00545	CbGpPWpGaD
Clevidipine—Nausea—Betamethasone—psoriasis	0.000226	0.00292	CcSEcCtD
Clevidipine—Nausea—Dexamethasone—psoriasis	0.000226	0.00292	CcSEcCtD
Clevidipine—Vomiting—Prednisone—psoriasis	0.000211	0.00272	CcSEcCtD
Clevidipine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000208	0.00498	CbGpPWpGaD
Clevidipine—Headache—Prednisone—psoriasis	0.000208	0.00268	CcSEcCtD
Clevidipine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.000206	0.00491	CbGpPWpGaD
Clevidipine—Hypersensitivity—Methotrexate—psoriasis	0.000204	0.00263	CcSEcCtD
Clevidipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000203	0.00484	CbGpPWpGaD
Clevidipine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000202	0.00483	CbGpPWpGaD
Clevidipine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000201	0.0048	CbGpPWpGaD
Clevidipine—Nausea—Prednisone—psoriasis	0.000197	0.00254	CcSEcCtD
Clevidipine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000192	0.00458	CbGpPWpGaD
Clevidipine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00019	0.00454	CbGpPWpGaD
Clevidipine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000189	0.00452	CbGpPWpGaD
Clevidipine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000187	0.00448	CbGpPWpGaD
Clevidipine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000186	0.00444	CbGpPWpGaD
Clevidipine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000185	0.00442	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000181	0.00432	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—CARM1—psoriasis	0.000179	0.00428	CbGpPWpGaD
Clevidipine—Vomiting—Methotrexate—psoriasis	0.000176	0.00227	CcSEcCtD
Clevidipine—Headache—Methotrexate—psoriasis	0.000174	0.00224	CcSEcCtD
Clevidipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000173	0.00414	CbGpPWpGaD
Clevidipine—CACNA1S—Alzheimers Disease—TNF—psoriasis	0.000172	0.0041	CbGpPWpGaD
Clevidipine—BCHE—Peptide hormone metabolism—LEP—psoriasis	0.000171	0.00409	CbGpPWpGaD
Clevidipine—Nausea—Methotrexate—psoriasis	0.000165	0.00212	CcSEcCtD
Clevidipine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000162	0.00388	CbGpPWpGaD
Clevidipine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.00016	0.00383	CbGpPWpGaD
Clevidipine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.00016	0.00382	CbGpPWpGaD
Clevidipine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000157	0.00376	CbGpPWpGaD
Clevidipine—CACNA1S—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000156	0.00373	CbGpPWpGaD
Clevidipine—CACNA1S—Alzheimers Disease—TP53—psoriasis	0.000151	0.00362	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—CARM1—psoriasis	0.000146	0.00348	CbGpPWpGaD
Clevidipine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000141	0.00338	CbGpPWpGaD
Clevidipine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.00014	0.00335	CbGpPWpGaD
Clevidipine—CACNA1D—Alzheimers Disease—TNF—psoriasis	0.000139	0.00333	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—NDUFA5—psoriasis	0.000139	0.00333	CbGpPWpGaD
Clevidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000134	0.00319	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—CARM1—psoriasis	0.000128	0.00306	CbGpPWpGaD
Clevidipine—CACNA1D—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000127	0.00303	CbGpPWpGaD
Clevidipine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000125	0.00299	CbGpPWpGaD
Clevidipine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000124	0.00295	CbGpPWpGaD
Clevidipine—CACNA1D—Alzheimers Disease—TP53—psoriasis	0.000123	0.00294	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—TNF—psoriasis	0.000123	0.00293	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—NDUFA5—psoriasis	0.000123	0.00293	CbGpPWpGaD
Clevidipine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000121	0.00288	CbGpPWpGaD
Clevidipine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.00012	0.00287	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—CYP2S1—psoriasis	0.000119	0.00283	CbGpPWpGaD
Clevidipine—CACNA1C—NCAM signaling for neurite out-growth—IL6—psoriasis	0.000112	0.00266	CbGpPWpGaD
Clevidipine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000111	0.00264	CbGpPWpGaD
Clevidipine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000108	0.00258	CbGpPWpGaD
Clevidipine—CACNA1C—Alzheimers Disease—TP53—psoriasis	0.000108	0.00258	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CYP2S1—psoriasis	0.000104	0.00249	CbGpPWpGaD
Clevidipine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	9.37e-05	0.00224	CbGpPWpGaD
Clevidipine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.32e-05	0.00223	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—TYK2—psoriasis	9.17e-05	0.00219	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—LEP—psoriasis	8.57e-05	0.00205	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—NDUFA5—psoriasis	8.39e-05	0.002	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—REN—psoriasis	8.33e-05	0.00199	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.82e-05	0.00187	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	7.78e-05	0.00186	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—PPARG—psoriasis	7.46e-05	0.00178	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—TYK2—psoriasis	7.44e-05	0.00178	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CYP2S1—psoriasis	7.13e-05	0.0017	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—LEP—psoriasis	6.96e-05	0.00166	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	6.73e-05	0.00161	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TYK2—psoriasis	6.54e-05	0.00156	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—TYK2—psoriasis	6.54e-05	0.00156	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—VEGFA—psoriasis	6.48e-05	0.00155	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	6.48e-05	0.00155	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—LEP—psoriasis	6.11e-05	0.00146	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—PPARG—psoriasis	6.06e-05	0.00145	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	5.88e-05	0.0014	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—CARM1—psoriasis	5.79e-05	0.00138	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NDUFA5—psoriasis	5.43e-05	0.0013	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—PPARG—psoriasis	5.32e-05	0.00127	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TYK2—psoriasis	5.31e-05	0.00127	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—VEGFA—psoriasis	5.26e-05	0.00126	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—ACE—psoriasis	5.2e-05	0.00124	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—NFKB1—psoriasis	5.1e-05	0.00122	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CARM1—psoriasis	5.09e-05	0.00122	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	5.04e-05	0.0012	CbGpPWpGaD
Clevidipine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	5.04e-05	0.0012	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TYK2—psoriasis	4.67e-05	0.00111	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—VEGFA—psoriasis	4.63e-05	0.0011	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—VEGFA—psoriasis	4.62e-05	0.0011	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CYP2S1—psoriasis	4.62e-05	0.0011	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—STAT3—psoriasis	4.58e-05	0.00109	CbGpPWpGaD
Clevidipine—CACNA1S—Axon guidance—IL6—psoriasis	4.48e-05	0.00107	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NDUFA5—psoriasis	4.19e-05	0.001	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—NFKB1—psoriasis	4.14e-05	0.000988	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TNF—psoriasis	3.96e-05	0.000947	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.91e-05	0.000934	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.86e-05	0.000921	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NDUFA5—psoriasis	3.82e-05	0.000913	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—VEGFA—psoriasis	3.76e-05	0.000897	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.74e-05	0.000893	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—STAT3—psoriasis	3.72e-05	0.000888	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—IL6—psoriasis	3.64e-05	0.000869	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—NFKB1—psoriasis	3.64e-05	0.000868	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CYP2S1—psoriasis	3.57e-05	0.000851	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.56e-05	0.000851	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—CAT—psoriasis	3.56e-05	0.000851	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CARM1—psoriasis	3.48e-05	0.000832	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—VEGFA—psoriasis	3.3e-05	0.000788	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP2S1—psoriasis	3.28e-05	0.000783	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—STAT3—psoriasis	3.27e-05	0.00078	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NDUFA5—psoriasis	3.27e-05	0.00078	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.26e-05	0.000778	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP2S1—psoriasis	3.25e-05	0.000776	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—LEP—psoriasis	3.23e-05	0.000771	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TNF—psoriasis	3.22e-05	0.000769	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—IL6—psoriasis	3.2e-05	0.000764	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—IL6—psoriasis	3.2e-05	0.000764	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CAT—psoriasis	3.13e-05	0.000747	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.05e-05	0.000728	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TNF—psoriasis	2.83e-05	0.000675	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP2S1—psoriasis	2.78e-05	0.000663	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—APOE—psoriasis	2.77e-05	0.000661	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—IL6—psoriasis	2.6e-05	0.00062	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.52e-05	0.000602	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—APOE—psoriasis	2.43e-05	0.000581	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PPARG—psoriasis	2.41e-05	0.000576	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—IL6—psoriasis	2.28e-05	0.000545	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CARM1—psoriasis	2.26e-05	0.000539	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—CXCL8—psoriasis	2.15e-05	0.000513	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP2S1—psoriasis	2.14e-05	0.000512	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CAT—psoriasis	2.14e-05	0.000512	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PPARG—psoriasis	2.12e-05	0.000506	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.87e-05	0.000446	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CARM1—psoriasis	1.74e-05	0.000416	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.7e-05	0.000407	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—APOE—psoriasis	1.66e-05	0.000398	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.63e-05	0.000389	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CARM1—psoriasis	1.6e-05	0.000382	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CARM1—psoriasis	1.59e-05	0.000379	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.48e-05	0.000354	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.46e-05	0.000348	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PPARG—psoriasis	1.45e-05	0.000346	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CAT—psoriasis	1.39e-05	0.000332	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CARM1—psoriasis	1.36e-05	0.000324	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.27e-05	0.000303	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—APOE—psoriasis	1.08e-05	0.000258	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CAT—psoriasis	1.07e-05	0.000256	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CARM1—psoriasis	1.05e-05	0.00025	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CAT—psoriasis	9.85e-06	0.000235	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CAT—psoriasis	9.76e-06	0.000233	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PPARG—psoriasis	9.39e-06	0.000224	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CAT—psoriasis	8.34e-06	0.000199	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—APOE—psoriasis	8.32e-06	0.000199	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—APOE—psoriasis	7.65e-06	0.000183	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—APOE—psoriasis	7.59e-06	0.000181	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PPARG—psoriasis	7.25e-06	0.000173	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PPARG—psoriasis	6.67e-06	0.000159	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PPARG—psoriasis	6.61e-06	0.000158	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—APOE—psoriasis	6.48e-06	0.000155	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CAT—psoriasis	6.44e-06	0.000154	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PPARG—psoriasis	5.65e-06	0.000135	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—APOE—psoriasis	5e-06	0.00012	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PPARG—psoriasis	4.36e-06	0.000104	CbGpPWpGaD
